| pubmed-article:9586875 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9586875 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:9586875 | lifeskim:mentions | umls-concept:C0024881 | lld:lifeskim |
| pubmed-article:9586875 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:9586875 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:9586875 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:9586875 | lifeskim:mentions | umls-concept:C0677929 | lld:lifeskim |
| pubmed-article:9586875 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:9586875 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:9586875 | pubmed:dateCreated | 1998-6-4 | lld:pubmed |
| pubmed-article:9586875 | pubmed:abstractText | Adjuvant loco-regional radiation (XRT) frequently is recommended after mastectomy and adjuvant systemic therapy in patients with 10 or more positive axillary lymph nodes (ALN) to reduce the high loco-regional failure rate observed in this subset. In this study, we explored the possibility that adjuvant loco-regional radiation therapy (LR-XRT) also could decrease distant failure and improve overall survival (OS) in this subset of poor-prognosis patients. | lld:pubmed |
| pubmed-article:9586875 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9586875 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9586875 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9586875 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9586875 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9586875 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9586875 | pubmed:month | May | lld:pubmed |
| pubmed-article:9586875 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:9586875 | pubmed:author | pubmed-author:OsborneC KCK | lld:pubmed |
| pubmed-article:9586875 | pubmed:author | pubmed-author:ClarkG MGM | lld:pubmed |
| pubmed-article:9586875 | pubmed:author | pubmed-author:RavdinP MPM | lld:pubmed |
| pubmed-article:9586875 | pubmed:author | pubmed-author:HilsenbeckS... | lld:pubmed |
| pubmed-article:9586875 | pubmed:author | pubmed-author:ElledgeR MRM | lld:pubmed |
| pubmed-article:9586875 | pubmed:author | pubmed-author:de MoorCC | lld:pubmed |
| pubmed-article:9586875 | pubmed:author | pubmed-author:DiabS GSG | lld:pubmed |
| pubmed-article:9586875 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9586875 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:9586875 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9586875 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9586875 | pubmed:pagination | 1655-60 | lld:pubmed |
| pubmed-article:9586875 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:meshHeading | pubmed-meshheading:9586875-... | lld:pubmed |
| pubmed-article:9586875 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9586875 | pubmed:articleTitle | Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy. | lld:pubmed |
| pubmed-article:9586875 | pubmed:affiliation | Division of Medical Oncology, University of Texas Health Science Center at San Antonio, 78284-7884, USA. sami_diab@oncology.uthscsa.edu | lld:pubmed |
| pubmed-article:9586875 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9586875 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9586875 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9586875 | lld:pubmed |
